National Health Act 1953 Amendment determination under section 99ADB weighted average disclosed price (No. PB 105 of 2009) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 105 of 2009

Amendment determination under section 99ADB of the National Health Act 1953

I, LINDA JACKSON, Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 99ADB of the National Health Act 1953.

Dated   1 October 2009

LINDA JACKSON

Assistant Secretary

Pharmaceutical Evaluation Branch

Department of Health and Ageing

Amendment determination – weighted average disclosed price

1          Commencement

This instrument commences on registration on the Federal Register of Legislative Instruments.

2           Amendment of PB 74 of 2009

Schedule 1 and 2 amend PB 74 of 2009.

3           Amendment to Determination pursuant to subsection 99ADB(4)   

Schedule 1 of the determination pursuant to subsection 99ADB(4) made on 30 July 2009 and registered on 30 July 2009  (PB 74 of 2009) is amended as set out in Schedule 1 to this instrument.

4           Amendment to Determination pursuant to subsection 99ADB(5)   

Schedule 2 of the determination pursuant to subsection 99ADB(5) made on 30 July 2009 and registered on 30 July 2009  (PB 74 of 2009) is amended as set out in Schedule 2 to this instrument.

Schedule 1  Amendments

Omit the following:

Meloxicam	Tablet 7.5 mg	Oral	GenRx Meloxicam	$9.84
Meloxicam	Tablet 15 mg	Oral	GenRx Meloxicam	$14.34

and substitute the following in the order indicated:

Meloxicam	Tablet 7.5 mg	Oral	GenRx Meloxicam	$10.62
Meloxicam	Tablet 15 mg	Oral	GenRx Meloxicam	$15.49

Schedule 2   Amendments

[1]

Omit

Meloxicam Capsule  7.5 mg Oral Movalis 7.5 $9.84

and substitute

Meloxicam Capsule  7.5 mg Oral Movalis 7.5 $10.62

[2]

Omit

Meloxicam Capsule  15  mg Oral Movalis 15 $14.34

and substitute

Meloxicam Capsule  15  mg Oral Movalis 15 $15.49